The effect of intra-vaginal oxytocin on sexual function in breastfeeding mothers: a randomized triple-blind placebo-controlled trial

Table 3 The mean sexual satisfaction total score and its dimensions in study groups

Variable (Score range)	Oxytocin n= 34	Placebo n= 30	AMD )95% CI)^b	P-value
Variable (Score range)	Mean (SD)^a	Mean (SD)^a	AMD )95% CI)^b	P-value
Contentment (6-30)
Baseline	19.21 (4.33)	22.7 (4.6)
8 weeks	21.56 (3.98)	23.17 (4.62)	1.56 (2.83 to 0.29)	0.017
Communication (6-30)
Baseline	20.50 (3.49)	22.7 (3.39)
8 weeks	21.23 (4.42)	23.40 (3.52)	0.23 (1.49 to -1.03)	0.716
Coping (6-30)
Baseline	18.85 (5.21)	22.13 (4.31)
8 weeks	19.68 (5.45)	22.27 (4.42)	0.12 (1.45 to -1.21 )	0.856
Relation concern (6-30)
Baseline	20.26 (4.39)	21.53 (5.17)
8 weeks	22.71 (8.65)	22.27 (4.93)	1.64 (4.67 to -1.32)	0.271
Personal concern (6-30)
Baseline	19.53 (5.42)	20.23 (5.84)
8 weeks	21.26 (5.59)	21.70 (5.11)	0.47 (1.822 to 0.9 )	0.498
Total Sexual Satisfaction (30-150)
Baseline	98.35 (17.64)	109.37 (15.94)
8 weeks	106.44 (21.7)	113.2 (16.48)	5.01 (10.56 to -0.53)	0.075

^a Mean (Standard Deviation)
^b Adjusted mean difference (95% confidence interval)
ANCOVA test adjusted for baseline score was used to compare the mean scores at post-intervention
Higher scores indicate high sexual satisfaction

ISSN: 1471-2393